Juno Diagnostics

San Diego, United States

Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.

$200K raised

Mar 2023

Undisclosed

Biotechnology Health Care Health Diagnostics

Top Investors

Perceptive Advisors Colle Capital Partners Zoic Capital Bioverge Milad Alucozai

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Juno Diagnostics

How much funding has Juno Diagnostics raised?

Juno Diagnostics has raised $200K in total funding. The most recent round was Undisclosed. The last funding was announced in March 2023.

Who are Juno Diagnostics's investors?

Juno Diagnostics's investors include Perceptive Advisors, Colle Capital Partners, Zoic Capital, Bioverge, Milad Alucozai.

Where is Juno Diagnostics headquartered?

Juno Diagnostics is headquartered in San Diego, United States.

What does Juno Diagnostics do?

Juno Diagnostics is a healthcare technology company developing the next generation cell-free DNA-based noninvasive prenatal test solutions.

What stage is Juno Diagnostics at?

Juno Diagnostics is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 10, 2023.

MLA

"Juno Diagnostics — Funding & Investors." VCBacked, March 10, 2023, https://www.vcbacked.co/company/juno-diagnostics. Accessed July 3, 2026.

APA

VCBacked. (2023). Juno Diagnostics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/juno-diagnostics

Wikipedia (cite web)

{{cite web |title=Juno Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/juno-diagnostics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 10, 2023.

Similar Companies in Biotechnology

View all

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Advanced Microbiome Interventions

Amsterdam$300K